长期前列腺癌幸存者的自我管理:一项随机对照试验
该随机对照试验纳入556名治疗后超过1年仍有症状负担的前列腺癌幸存者,比较个体化自动电话症状管理干预与强化常规护理(加发非个体化症状管理简讯)的效果。干预组在5个月时各领域EPIC评分较高但差异无统计学意义,应对评估较高(2.8 vs 2.6;P = .02);亚组分析中干预组在5个月和12个月时其症状关注领域较基线改善。
要点
- 干预组5个月时各领域EPIC评分均高于对照组,但差异无统计学意义。
- 干预组5个月时应对评估高于对照组(2.8 vs 2.6;P = .02)。
- 亚组分析中干预组在其症状关注领域于5个月和12个月较基线改善。
核心结论
- 该干预在长期前列腺癌幸存者中接受度良好;虽未观察到组间总体结局差异,但针对所选症状领域的个体化干预可能有望改善相关负担。
研究设计与样本
- 随机对照试验,2015年4月至2017年2月从4个退伍军人事务站点招募556名治疗后超过1年仍有症状负担的前列腺癌幸存者,随机分为干预组(n = 278)和常规护理组(n = 278),采用意向性治疗分析比较主要结局(EPIC-26症状负担、自我管理信心)和次要结局。
主要发现
- 研究对象中已婚者占54.3%,白人占69.2%,退休者占62.4%,接受放疗者占56.7%(接受手术者占46.2%),平均年龄67岁;两组基线泌尿、肠道、性功能及激素领域EPIC评分无差异。
- 干预组5个月时所有领域EPIC评分均高于对照组,但差异无统计学意义。
- 次要结局无差异;干预组5个月时应对评估高于对照组(2.8 vs 2.6;P = .02)。
- 亚组分析中,干预组在其症状关注领域于5个月和12个月较基线改善。
临床怎么用
- 作者认为,针对所选症状领域的个体化干预可能有望改善相关负担。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This randomized clinical trial compared a personally tailored, automated telephone symptom management intervention to improve self-management among long-term survivors of prostate cancer with usual care enhanced with a nontailored newsletter about symptom management. We hypothesized that intervention-group participants would have more confident symptom self-management and reduced symptom burden. METHODS: A total of 556 prostate cancer survivors who, more than 1 year after treatment, were experiencing symptom burden were recruited from April 2015 to February 2017 across four Veterans Affairs sites. Participants were randomly assigned to intervention (n = 278) or usual care (n = 278) groups. We compared differences in the primary (symptom burden according to Expanded Prostate Cancer Index Composite-26 [EPIC], confidence in self-management) and secondary outcomes between groups using intent-to-treat analyses. We compared domain-specific changes in symptom burden from baseline to 5 and 12 months among the intervention group according to the primary symptom focus area (urinary, bowel, sexual, general) of participants. RESULTS: Most of the prostate cancer survivors in this study were married (54.3%), were white (69.2%), were retired (62.4%), and underwent radiation therapy (56.7% v 46.2% who underwent surgery), and the mean age was 67 years. There were no baseline differences in urinary, bowel, sexual, or hormonal domain EPIC scores across groups. We observed higher EPIC scores in the intervention arm in all domain areas at 5 months, though differences were not statistically significant. No differences were found in secondary outcomes; however, coping appraisal was higher (2.8 v 2.6; P = .02) in intervention-arm patients at 5 months. In subgroup analyses, intervention participants reported improvement from baseline at 5 and 12 months in their symptom focus area domains. CONCLUSION: This intervention was well received among veterans who were long-term survivors of prostate cancer. Although overall outcome differences were not observed across groups, the intervention tailored to symptom area of choice may hold promise to improve associated burden.
引用
- Skolarus TA, Metreger T, Wittmann D, et al. Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial. J Clin Oncol. 2019. PMID: 30925126. doi:10.1200/JCO.18.01770
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。